Excedr

"It really comes down to a lot of decisions when you're doing a startup. It is just being naive enough to not know just how insane and hard it's gonna be, and also just taking that leap of faith and trusting your own ability." In Part 3 of The Biotech Startups Podcast conversation with LatchBio Co-Founder & CEO Alfredo Andere, we explore the power of naivety and self-belief in entrepreneurship. In this episode, we cover: – The journey from dropping out of college to founding a biotech startup – The importance of market research and customer feedback in the early stages – The stark contrast between cutting-edge tech companies and the outdated tools in biotech – The exponential growth of biodata and the need for better infrastructure – The value of having a long-term vision when choosing startup ideas This episode offers invaluable insights into the challenges and opportunities in the biotech industry, showcasing how a fresh perspective can lead to groundbreaking innovations. Head over to Apple Podcasts or Spotify for this episode and more stories only a biotech exec can tell! #biotechnology #lifesciences #podcast

Here’s the list of tech I use to record The Biotech Startups Podcast: 1. Zoom 2. A $10 ring light 3. A Twitch streaming camera that was like $70 4. A $120 microphone That’s it. That’s the list. And really? You could do it with the camera in your laptop and some Airpods. It doesn’t take fancy tech or anything else. One of the biggest YouTube game-streamers, has 10s of millions of subscribers…. And he just uses his iPhone camera. Content > Production. If you have an idea for a podcast, don’t let shopping for equipment get in your way. Start now. Upgrade (totally optional) later. #lifesciences #biotechnology #podcast

Sometimes it takes a moment of clarity to realize what you're truly passionate about—going all-in on that vision can lead to a lifelong journey of purpose and impact! 💡🔬 #BiotechJourney #LongTermVision #TheBiotechStartupsPodcast

"Kyle Giffin and Kenny Workman are two of the most special human beings I know. The way the three of us worked together—iterating on ideas, disagreeing, agreeing on fundamental values, and debating passionately—helped us arrive at higher truths." 🚀💡 In Part 3 of my conversation with Alfredo Andere 🦖, Co-Founder & CEO of LatchBio on The Biotech Startups Podcast, we dive deep into the power of collaboration and the journey of building a revolutionary biotech startup. Below are some highlights from our conversation: – 🤝 The importance of finding the right co-founders and building a strong team dynamic – 🧬 The genesis of LatchBio and identifying the need for better data infrastructure in biotech – 💻 Transitioning from academia to entrepreneurship and the challenges faced along the way – 🌐 The vision of creating a cloud computing platform specifically tailored for biotech companies – 🔬 How LatchBio is accelerating research by bridging the gap between wet lab scientists and computational biologists Alfredo's insights on teamwork, innovation, and the future of biotech are seriously inspiring. This episode is jam packed with valuable lessons for aspiring entrepreneurs and biotech professionals alike! Apple Podcasts & Spotify links in the comments below! 👇🏽 #biotechnology #lifesciences #podcast

Building something without user feedback can lead to a product that nobody needs—don't make that mistake! 🚫💻 #ListenToUsers #StartupLessons #TheBiotechStartupsPodcast

Managing a student club may seem small, but it teaches you the foundational skills to lead teams—apply those lessons and watch your leadership grow! 💼📈 #LeadershipLessons #TeamManagement #TheBiotechStartupsPodcast

Getting involved in student-run organizations can be life-changing—build lifelong connections, nurture like-minded friendships, and unlock opportunities that stay with you forever! 🌈📚 #StudentOrgs #BiotechCommunity #TheBiotechStartupsPodcast

I got rejected from every college I applied to—except one. UC Irvine, UC Santa Barbara, all said no. But somehow, UC Berkeley EECS (one of the world's most competitive CS programs) accepted me early. At least it made my "decision" pretty easy. I still don't know what they saw in my application, but I'm very grateful they saw something different. Hope to pay it back someday. Go Bears! - More stories in my conversation with Jon Chee on the Biotech Startups Podcas

"We believe if we can build good software here, we can completely automate that whole part of experimentation, and not just automate, but also empower the people that are doing the more complex analysis." 💻 🧬 In part 2 of my conversation with Alfredo Andere 🦖, Co-Founder & CEO of LatchBio, on The Biotech Startups Podcast, we dive into his journey of empowering scientists through innovative software solutions. Some highlights from our conversation below: – 🎓 Alfredo's unique path from Mexico to University of California, Berkeley, and his "time chamber" experience of intense learning 📚 – 🤖 🚀 His leadership in Machine Learning at Berkeley and how it shaped his entrepreneurial vision – 💼 🩺 Valuable internship experiences at Facebook, Google, and University of California, San Francisco, and the lessons learned from each – 🧠 The initial spark that led to LatchBio, starting with neuroscience projects and pivoting to biotech – 🗣️ The importance of talking to users and solving real problems in the startup journey Alfredo's story is a testament to the power of persistence, curiosity, and the impact of surrounding yourself with like-minded individuals. His insights are invaluable for anyone interested in the intersection of tech and biotech. Apple Podcasts & Spotify links in the comments below! 👇🏽 #biotechnology #lifesciences #podcast

What truly excites me about our AUTX-703 program is the mechanism we’ve uncovered – targeting the cell state driver KAT2A promotes differentiation and obstructs growthirrespective of underlying genomic mutations. With treatment extending out past 100 days we are pleased to see durable effects on cell state differentiation in preclinical models of solid tumors. I’m grateful to our dedicated team for their unwavering commitment to transforming treatment paradigms for patients with limited options. #SCLC25